TAMPA, Fla. – Moffitt Cancer Center and Florida Governor Rick Scott announced today that the cancer center has been awarded the National Cancer Institute’s highest designation – Comprehensive Cancer Center. Only four percent of cancer research institutions in the United States have received the prestigious designation. Comprehensive Cancer Center status recognizes robust clinical, basic and population science research; team science; scientific leadership; education programs; and research focused on benefitting the community. Moffitt is the only Comprehensive Cancer Center based in the state of Florida, which has the second highest burden of cancer incidence and death in the United States.
“Designation is a testament to Moffitt’s strong focus on translating our research discoveries into new therapies for our patients. When you are treated at a NCI-designated Comprehensive Cancer Center, you receive what will be the standard of care tomorrow, today. This is because NCI-designated centers provide patients with access to cutting-edge therapies and clinical trials,” said Moffitt Center Director Thomas A. Sellers, Ph.D., M.P.H.
“I am very excited to announce that Moffitt Cancer Center has been awarded the NCI Comprehensive Cancer Center designation. This recognition shows Moffitt’s commitment to providing world-class care for people affected by the devastating effects of cancer. Since 2014, we have invested $180 million in Florida’s top cancer research centers to improve cancer care and create a premier top cancer research network in Florida. We will continue working to make Florida the best state for cancer research and treatment,” said Gov. Scott.
The NCI Cancer Centers Program is an integral part of the nation’s cancer research effort. Moffitt’s Comprehensive Cancer Center designation comes with grant funding for research programs, shared resources, and developmental funds to advance multidisciplinary science. The rapid pace of discovery and the improved cancer treatments that designated centers help pioneer have contributed substantially to the increase in the number of cancer survivors in the U.S., as well as to the quality of their lives.
“Through our ongoing research efforts and robust portfolio of clinical trials, Moffitt is achieving better cancer outcomes than the national average, and providing our patients with higher-quality lives. We are continually moving forward by identifying cancer causes, developing prevention strategies and discovering new and better treatments,” said Sellers.
“Moffitt was established in 1981 by the Florida Legislature to address the state’s cancer burden. The institution opened its doors five years later. Our single focus is to contribute to the prevention and cure of cancer. This year, we celebrate 30 years and in that time have grown to become the No. 6 cancer hospital in the nation and top-ranked cancer hospital in the Southeast based on U.S. News & World Report ‘Best Hospitals’ rankings. And we have made a lasting impact on cancer care through research breakthroughs in myelodyspastic syndromes, melanoma, lung and several other cancers,” said Alan F. List, M.D., president and CEO of Moffitt.
Moffitt first began its research efforts in 1993. Five years later in 1998, the institution received its initial NCI Cancer Center designation. Moffitt continued to build on its research excellence and achieved the prestigious NCI Comprehensive Cancer Center designation in 2001. It has been able to retain the designation through the rigorous renewal process every five years. Today, Moffitt’s research enterprise includes more than 150 investigators organized around five collaborative and multi-disciplinary scientific programs, all with an emphasis on translating cancer discoveries to enhance prevention and improve therapies.
Moffitt is one of only 47 NCI-designated Comprehensive Cancer Centers in the U.S.
"Moffitt’s ability to deliver care to Floridians not only, but also to patients throughout the country and world, is unmatched. Congratulations to Moffitt for their continued excellence in leading the fight to cure cancer," said State Rep. Janet Cruz, D – Tampa.
"The partnership between the State of Florida and Moffitt is one of our greatest successes. The impact Moffitt has made over the last 30 years on this state let alone the Moffitt patients and their families cannot be overstated,” said State Rep. James W. Grant, R – Tampa.
“Congratulations to Moffitt for once again being recognized by the National Cancer Institute as a Comprehensive Cancer Center. This honor is just one example of why we are so fortunate to have this world-class institute in our State,” said State Sen. Jack Latvala, R – Clearwater.
“The $2.1 billion economic impact on the Florida economy from Moffitt is an incredible asset, employing over 5,000 Floridians. Moffitt is a tremendous community asset for Tampa and a gem for the entire state. The partnership between the State of Florida and this world class facility will provide an amazing return on investment as we continue to pursue innovative breakthroughs in the fight to cure cancer," said State Rep. Dana Young, R – Tampa.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 47 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, clinical trials, prevention and cancer control. Moffitt is the No. 6 cancer hospital in the nation and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2.5 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 5,200 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube.